Formulated with Proprietary Cannabinoid Blend and Clinically Proven Ingredient to Address Pain
Charlotte, North Carolina–(Newsfile Corp. – October 18, 2022) – cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation’s leading, highly trusted and widely recognized CBD companies, announced their latest product launch geared toward the over 50 million Americans who suffer from some form of everyday pain or discomfort. cbdMD MAX features their innovative formula that combines cbdMD’s proprietary cannabinoid blend with Univestin.®
cbdMD’s human clinical study has demonstrated that its proprietary blend reduces pain in healthy adults. Univestinis an award-winning, clinically proven ingredient that combines two medicinal plants, which have a long legacy of safe human consumption. With the power of cbdMD’s proprietary blend and the proven benefits of Univestin, cbdMD has created an innovative new product to help those suffering from everyday pain.
“We are constantly pushing the boundaries of innovation bringing our customers trusted, everyday wellness solutions,” said Kevin MacDermott, President of cbdMD. “This latest undertaking combines the well-known powers of cannabinoids with another functional ingredient providing our customers a botanically-derived, effective solution to help them manage everyday pain and be their best.”
